Related Experiment Video
Updated: Apr 19, 2026
07:35
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
7.6K
[DR3/LARD mRNA spliced variants' frequency at colorectal cancer]
Molekuliarnaia Biologiia
|December 17, 2014
Summary
Alternative splicing creates death receptor DR3/LARD mRNA variants. Colon cancer patients exhibit reduced DR3/LARD mRNA diversity, particularly a decrease in soluble DR3beta mRNA, impacting apoptosis signaling.
Area of Science:
- Molecular biology
- Cancer research
- Immunology
Context:
- Alternative splicing of death receptor DR3/LARD mRNA generates diverse functional variants.
- Membrane and soluble forms of DR3/LARD receptor play distinct roles in cellular processes.
- Understanding DR3/LARD mRNA variant expression is crucial for cancer biology.
Purpose:
- To investigate the frequency and diversity of DR3/LARD mRNA spliced variants in colon cancer.
- To compare DR3/LARD mRNA expression patterns between healthy individuals and colon cancer patients.
- To determine the association between DR3/LARD mRNA variant spectrums and colon cancer development.
Summary:
- RT-PCR analysis revealed four DR3/LARD mRNA variants: two membrane-bound (LARD la, DR3beta) and two soluble (LARD 3, soluble DR3beta).
- Healthy volunteers displayed 11 DR3/LARD mRNA spectrums, dominated by the "full" spectrum. Colon cancer patients and tumor tissues showed 6 spectrums.
- A significant reduction in DR3/LARD mRNA diversity was observed in colon cancer patients, primarily due to decreased frequency of soluble DR3beta mRNA.
Impact:
- The study identifies specific DR3/LARD mRNA spectrums associated with colon cancer, highlighting altered expression patterns.
- Reduced diversity in DR3/LARD mRNA variants, particularly soluble DR3beta, may influence immune cell and tumor cell susceptibility to apoptosis.
- Findings suggest potential diagnostic or prognostic biomarkers based on DR3/LARD mRNA expression profiles in colon cancer.
More Related Videos
09:16Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
Published on: February 5, 2018
6.7K
11:20Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
11.6K
Related Concept Videos
03:18Non-LTR Retrotransposons
14.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.1K
01:32RNA Splicing
61.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.9K